Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Muscle Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Connective and Soft Tissue Neoplasm
Musculoskeletal Neoplasm
Muscle Neoplasm

Subtype

Muscle Neoplasm

CI-CAN-00001246Explore in graph →

Non-malignant151 active trials1 approved drugs38 evidence items

NCIt: C4063
MeSH: D019042

Overview
Statistics
Survival
Genomics4
Variants & evidence38
Drugs4
Trials760
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (26)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–25 of 26 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
· J Clin Oncol · 2002 · PMID 12039929 · validated civic_curation pubmed
MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
· Mod Pathol · 2016 · PMID 27562493 · validated civic_curation pubmed
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
· J Clin Oncol · 2021 · PMID 34166060 · validated civic_curation pubmed
A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.
· Am J Surg Pathol · 2016 · PMID 26501226 · validated civic_curation pubmed
Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
· Genes Chromosomes Cancer · 2014 · PMID 24824843 · validated civic_curation pubmed
Clinicopathologic features and molecular spectrum of spindle cell and sclerosing rhabdomyosarcomas in the head and neck region.
· Int J Clin Exp Pathol · 2018 · PMID 31949721 · validated civic_curation pubmed
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.

Showing 1–25 of 26 publications

← Previous
1
2
Next →

· Cancer Discov · 2014 · PMID 24436047 · validated cbioportal_study pubmed

Evolving classification of rhabdomyosarcoma.

· Histopathology · 2022 · PMID 34958505 · validated civic_curation pubmed

Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases.

· Mod Pathol · 2025 · PMID 41075874 · validated civic_curation pubmed

The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.

· Histopathology · 2019 · PMID 30604891 · validated civic_curation pubmed

A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation.

· Mod Pathol · 2020 · PMID 31383960 · validated civic_curation pubmed

Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.

· Eur J Cancer · 2022 · PMID 35452896 · validated civic_curation pubmed

Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.

· Am J Surg Pathol · 2019 · PMID 30720533 · validated civic_curation pubmed

Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype.

· Histopathology · 2018 · PMID 29758589 · validated civic_curation pubmed

Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma.

· Genes Chromosomes Cancer · 2024 · PMID 39302072 · validated civic_curation pubmed

Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.

· Mod Pathol · 2023 · PMID 37422156 · validated civic_curation pubmed

Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.

· Cancer Med · 2020 · PMID 32087612 · validated civic_curation pubmed

Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.

· Genes Chromosomes Cancer · 2013 · PMID 23463663 · validated civic_curation pubmed

Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.

· Histopathology · 2021 · PMID 33382123 · validated civic_curation pubmed

Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings.

· Am J Surg Pathol · 2021 · PMID 33949344 · validated civic_curation pubmed

Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors.

· Cancer Res · 2009 · PMID 19366796 · validated civic_curation pubmed

PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.

· Cancer Discov · 2017 · PMID 28446439 · validated civic_curation pubmed

Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.

· PLoS One · 2017 · PMID 28672024 · validated civic_curation pubmed

de Wardin et al. JCO Precis Oncol 2023

· 2023 · PMID 37315267 · validated cbioportal_study pubmed

Wardin et at. NPJ Precis Oncol 2023

· 2023 · PMID 37730754 · validated cbioportal_study pubmed